McKesson distributes drugs and healthcare products to pharmacies and providers, and supplies medical products to clinics and care facilities. It last closed at $1091.70 on Nov 17, down 1.21% on the day. MCK reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 6 analysts is $1178.33 (+7.9% from the last close), with a high of $1255.00 and a low of $965.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in MCK, 0% of them bullish and 100% bearish. In the past 30 days there were 16 dark pool prints totaling $12.7M, the largest $1.9M.
Each firm's latest rating on MCK in the past 90 days
Average 12-month target
$1178.33
▲ 7.9% upside
Based on 6 analysts who set a price target on MCK in the past 90 days. The average target is $1178.33, with a high of $1255.00 and a low of $965.00, compared with the last close of $1091.70.
Low $965.00Avg $1178.33High $1255.00
Blue marker: last close $1091.70
Highest target$1255.00
Average target$1178.33
Lowest target$965.00
Latest rating changes
JP MorganMaintained
Nov 10Buy$1255
UBSTarget raised
Nov 6Buy$1200 → $1250
TD CowenTarget raised
Nov 5Buy$1006 → $1200
Leerink PartnersTarget raised
Nov 5Buy$1070 → $1200
RBC CapitalTarget raised
Nov 5Hold$845 → $965
Date
Firm
Action
Rating
Price target
Nov 10
JP Morgan
Maintained
Buy
$1255
Nov 6
UBS
Target raised
Buy
$1200 → $1250
Nov 5
TD Cowen
Target raised
Buy
$1006 → $1200
Nov 5
Leerink Partners
Target raised
Buy
$1070 → $1200
Nov 5
RBC Capital
Target raised
Hold
$845 → $965
Loading…
Technical Analysis
MCK · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 5% above its 20 day and 12% above its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 69), near overbought. The nearest support is the Pivot S1 at $1081.47, and the nearest resistance the Pivot at $1095.40.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 2.3%/day
Key levels
$1121.5052 week high+2.7%
$1121.50Swing high (Nov 5)+2.7%
$1105.63Pivot R1+1.3%
$1095.40Pivot+0.3%
$1091.70Last close
$1081.47Pivot S1−0.9%
$1036.2720 day average−5.1%
$963.1350 day average−11.8%
$954.05Swing low (Oct 28)−12.6%
$906.44100 day average−17.0%
$876.86200 day average−19.7%
$723.6852 week low−33.7%
Indicators
RSI (14)
69.23
Strong, overbought above 70
Neutral
MACD
38.68
Above its signal line
Bullish
Stochastic
86.8
Near the top of its range
Overbought
ADX (14)
36.6
Trending up
Williams %R
-19.0
Oversold below −80, overbought above −20
Overbought
CCI (20)
92.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+9.2%
Change over 10 sessions
Bullish
ATR (14)
$24.97
Typical daily range, 2.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityHigh, 5.2%/day
Key levels
$1121.5052 week high+2.7%
$1121.50Swing high (Nov 5)+2.7%
$1105.63Pivot R1+1.3%
$1095.40Pivot+0.3%
$1091.70Last close
$1081.47Pivot S1−0.9%
$1036.2720 day average−5.1%
$963.1350 day average−11.8%
$954.05Swing low (Oct 28)−12.6%
$906.44100 day average−17.0%
$876.86200 day average−19.7%
$723.6852 week low−33.7%
Indicators
RSI (14)
75.41
Overbought above 70
Overbought
MACD
63.01
Above its signal line
Bullish
Stochastic
87.9
Near the top of its range
Overbought
ADX (14)
32.5
Trending up
Williams %R
-10.5
Oversold below −80, overbought above −20
Overbought
CCI (20)
168.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+23.8%
Change over 10 sessions
Bullish
ATR (14)
$57.31
Typical daily range, 5.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for MCK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MCK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow MCK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How MCK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MCK is in one of them and how their past MCK trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Mckesson
McKesson is a healthcare company based in Irving, Texas. It distributes prescription and over the counter drugs and other healthcare products to pharmacies, hospitals, and physicians in the United States and Canada. It also provides technology and services that help patients get their medicines and help biopharma companies reach patients. The company supplies medical products to physician offices, surgery centers, and nursing homes.